Drug recall D-0808-2026
Product
Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50.
Reason for recall
CGMP Deviations
Lots and codes
Lot # NC193764, Exp Date: 10/18/2027; Lot # NC195232, Exp Date: 11/25/2027.
Recall details
- Recalling firm
- Baxter Healthcare Corporation, Deerfield, IL
- Quantity
- N/A
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 6, 2026
Related products
- Clindamycin phosphate – drug information
- NDC 0338-3814 Clindamycin phosphate · Clindamycin Phosphate 900 mg/50mL · Baxter Healthcare Company
- NDC 0338-3612 Clindamycin phosphate · Clindamycin Phosphate 600 mg/50mL · Baxter Healthcare Company
- NDC 0338-3410 Clindamycin phosphate · Clindamycin Phosphate 300 mg/50mL · Baxter Healthcare Company